Philosophers have long wrestled with what to do about the onlookers and profiteers surrounding those who have done terrible things. By Ginia Bellafante As millions of pages from the government files ...

A phase 3 study of Gossamer Bio’s seralutinib in pulmonary arterial hypertension (PAH) has missed its primary endpoint, triggering a 77% crash in the biotech’s share price. The company has paused ...

As Americans continue to peruse the chaotically organized Justice Department files on Jeffrey Epstein, President Trump announced late on Thursday that he would release more previously unseen files, ...

RIYADH - ImmunityBio, Inc. (NYSE:IBRX) held regulatory discussions with the Saudi Food and Drug Authority (SFDA) that advanced two key priorities for the company’s products in the Kingdom of Saudi ...

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Delta Air Lines (NYSE:DAL) has agreed to purchase 31 new Airbus widebody jets as part of a ...

In a report released today, Eliana Merle from Barclays maintained a Buy rating on Gossamer Bio, with a price target of $9.00. Merle covers the Healthcare sector, focusing on stocks such as Ultragenyx ...

Romance scams aren’t only heartbreaking. They are big business for criminals. Every year in the UK, there are more than 9,400 reports of romance fraud. This equates to a loss of more than £106m or ...

Scotland’s Speyside is preparing to welcome the world’s first luxury whisky resort, blending distilling heritage with high-end hospitality. Far from a drinking playground, the resort focuses on ...

Images and emails tying high-profile celebrities to Jeffrey Epstein have been released after the final batch of the Epstein files was shared last Friday (30 January). More than three million documents ...

WASHINGTON — The Justice Department told a judge Tuesday that it has reviewed "several million" pages of files related to Jeffrey Epstein in response to the Epstein Files Transparency Act. In the four ...

BALTIMORE, Jan. 12, 2026 /PRNewswire/ -- IndyGeneUS Bio today announced the filing of a patent application covering its Clinico-Genomic Insight Engine™ (CGIE™)—a foundational platform under ...